• USA Home
  • 330728P - C13 Galactosyl(β) Ceramide-d7 (d18:1-D7/13:0)

EMAIL THIS PAGE TO A FRIEND
330728P Avanti

C13 Galactosyl(β) Ceramide-d7 (d18:1-D7/13:0)

powder

Synonym: C13 Galactosyl(β) Ceramide-d7 (d18:1-D7/13:0)

  • Empirical Formula (Hill Notation) C37H64D7NO8

  • Molecular Weight 665.00

Purchase

Properties

Related Categories Avanti Polar Lipids Products, Avanti Stable Isotopes & ESR Probes, Biochemicals and Reagents, Lipids
form   powder
packaging   pkg of 1 × 1 mg (330728P-1MG)
mfr. no.   Avanti Polar Lipids (330728P)
application(s)   thin layer chromatography (TLC): 99%
shipped in   dry ice
storage temp.   −20°C
SMILES string   [H][C@](/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO

Description

General description

C13 Galactosyl(β) Ceramide-d7 (d18:1-D7/13:0) is deuterated derivative of C13 Galactosyl(β) Ceramide. β-Galactosyl ceramide (β −GalCer) is one of the uncomplicated glycosphingolipid. It contains a lipophilic sphingosine and a hydrophilic galactose moiety, which is attached to sphingosine via an ether linkage. It is localized in the myelin sheath of the peripheral and central nervous system.

Biochem/physiol Actions

β-Galactosyl ceramide (β −GalCer) plays a role in regulating the activity of β-glucocerebrosidase (β-GlcCer′ase). It is also a receptor for various bacterial and viral toxins.

Packaging

5 mL Amber Glass Screw Cap Vial

Safety & Documentation

Safety Information

Safety Information for this product is unavailable at this time.

Documents

Certificate of Analysis (COA)

Please Enter a Lot Number
Protocols & Articles
Peer-Reviewed Papers
15

References

Related Products

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?